Cite
Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects.
MLA
Ma, Jing, et al. “Glycosylated Platinum(Iv) Prodrugs Demonstrated Significant Therapeutic Efficacy in Cancer Cells and Minimized Side-Effects.” Dalton Transactions: An International Journal of Inorganic Chemistry, vol. 45, no. 29, Aug. 2016, pp. 11830–38. EBSCOhost, https://doi.org/10.1039/c6dt02207c.
APA
Ma, J., Wang, Q., Yang, X., Hao, W., Huang, Z., Zhang, J., Wang, X., & Wang, P. G. (2016). Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects. Dalton Transactions: An International Journal of Inorganic Chemistry, 45(29), 11830–11838. https://doi.org/10.1039/c6dt02207c
Chicago
Ma, Jing, Qingpeng Wang, Xiande Yang, Wenpei Hao, Zhonglv Huang, Jiabao Zhang, Xin Wang, and Peng George Wang. 2016. “Glycosylated Platinum(Iv) Prodrugs Demonstrated Significant Therapeutic Efficacy in Cancer Cells and Minimized Side-Effects.” Dalton Transactions: An International Journal of Inorganic Chemistry 45 (29): 11830–38. doi:10.1039/c6dt02207c.